Pilot Safety Evaluation of a Novel Strain of Bacteroides ovatus

Huizi Tan,Zhiming Yu,Chen Wang,Qingsong Zhang,Jianxin Zhao,Hao Zhang,Qixiao Zhai,Wei Chen
DOI: https://doi.org/10.3389/fgene.2018.00539
IF: 3.7
2018-11-06
Frontiers in Genetics
Abstract:<i>Bacteroides ovatus</i> ELH-B2 is considered as a potential next-generation probiotic due to its preventive effects on lipopolysaccharides-associated inflammation and intestinal microbiota disorders in mice. To study safety issues associated with <i>B. ovatus</i> ELH-B2, we conducted comprehensive and systematic experiments, including <i>in vitro</i> genetic assessments of potential virulence and antimicrobial resistance genes, and an <i>in vivo</i> acute toxicity study of both immunocompetent and immunosuppressed mice via cyclophosphamide treatment. The results indicated that this novel strain is non-toxigenic, fragilysin is not expressed, and most of potential virulence genes are correlated with cellular structures such as capsular polysaccharide and polysaccharide utilizations. The antibiotic resistance features are unlikely be transferred to other intestinal microorganisms as no plasmids nor related genomic islands were identified. Side effects were not observed in mice. <i>B. ovatus</i> ELH-B2 also alleviated the damages caused by cyclophosphamide injection.
genetics & heredity
What problem does this paper attempt to address?